Open AccessParticipant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer
Author(s) -
Nicole M. Kuderer,
Kimberly A. Burton,
Sibel Blau,
Francis M. Senecal,
Vijayakrishna K. Gadi,
Stephanie Parker,
Elisabeth Mahen,
David L. Veenstra,
Josh J. Carlson,
Gary H. Lyman,
C. Anthony Blau
Publication year - 2017
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.17.00076
Subject(s) - breast cancer , medicine , confidentiality , clinical trial , informed consent , cancer , family medicine , clinical psychology , psychology , oncology , alternative medicine , pathology , political science , law
Multidimensional molecular analysis of tumor tissue intensively over space and time can provide insight into how cancers evolve and escape treatment. Attitudes of participants in such trials have not been assessed. We explored patient views regarding an intensive study incorporating multiple biopsies, multidimensional molecular testing, and drug response predictions that are reported to the oncologist and patient.